 |
 |
Any chance of getting Dr. Levesque on the list ? Both sides could benefit... Quoting rayilynlee <[log in to unmask]>: > Dr. Levesque > > Thank you again for taking the time to respond to my questions and confirm > certain facts about this case. > > I assure you I never said you claimed a cure or successful treatment for > Dennis Turner, but other people have. You are to be commended for the > caveats and clarifications in some of the articles. currently on-line. > > I'm afraid most of the public won't read or understand the scientific > publication. > > Again, thank you, you've been most helpful. > > Rayilyn Brown > Director AZNPF > Arizona Chapter National Parkinson Foundation > [log in to unmask] > > > From: Michel Levesque, M.D. > Sent: Saturday, February 21, 2009 12:26 PM > To: rayilynlee > Cc: parkinsn ; [log in to unmask] ; [log in to unmask] ; > Dennis Turner > Subject: RE: Adult Stem Cell Treatment for Parkinson's > > > Dear Ms Lee, I will attempt to briefly answer your additional questions > below. > > > > How can the efficacy of the transplantation be accurately assessed if the > subject still takes PD meds and sometimes has a neurotransmitter turned on? > Clinical evaluation is made while "off" medication and "on" medication. This > is the standard evaluation for post transplantation patient. In Mr Turner > case, the evaluation was also performed while "off" his thalamic stimulator. > Our goal in the future is to stop all medications completely after > transplantation which will allow cells to function better > > > > Even though as you explain Turner's DBS was not targeted for STN, doesn't it > still qualify as a treatment? Mr. Turner was entered in the pilot Phase I > trial after our IRB committee would approve the transplantation only if the > initial harvesting was performed during a neurosurgical procedure of > electrode implantation. The upcoming Phase II trial, patients with previous > brain surgery or DBS will be excluded from entering the trial. > > > > DBS is now being targeted to areas of the brain to alleviate clinical > depression and epilepsy. Why does my DBS exclude me from Phase II and > Turner's was a part of his treatment package? See above. > > > > It seems to me that Turner's PD symptoms returned at least five years ago. > His head was shaking in the 2004 video of his senate testimony. Why has the > peer evaluation taken so long? Indeed his symptoms returned after 5 years > post-op. I do not present this as a "cure" and never did. The peer-reviewed > paper took years to be submitted because the data and all microphotographs > belonged to the previous Celmed company, and they were reacquired by > NeuroGeneration in 2005. In addition, patent attorneys opposed the > publication until they completed their filing with the USPTO. > > > > The fact that his PD returned is never stated in the publicity surrounding > Turner. What kind of difference would it make if it was? This clearly > stated in our scientific publication. > > > > > > Sincerely yours, > > M.Levesque, MD > > > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto:[log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------- This mail sent through http://www.ukonline.net ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn